Pharmalogic ApS Financials, key figures and credit report
Gross profit 25 106.3 kDKK FY 2025 +18.7% vs 2024
EBIT 1 343.1 kDKK FY 2025 +2,111% vs 2024
Net debt 563.0 kDKK FY 2025 -52.8% vs 2024
Quick ratio 1.1 FY 2025 +0.1 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 3 240.65 | 7 396.26 | 15 246.34 | 21 156.00 | 25 106.32 |
| Employee benefit expenses | -2 562.48 | -6 573.40 | -13 413.83 | -21 157.37 | -23 645.89 |
| Other operating expenses | -26.75 | ||||
| Total depreciation | -0.00 | -79.75 | -64.14 | -65.41 | - 117.30 |
| EBIT | 678.17 | 743.11 | 1 741.63 | -66.79 | 1 343.13 |
| Other financial expenses | -0.96 | -38.12 | -45.48 | - 122.92 | - 113.67 |
| Pre-tax profit | 677.21 | 704.99 | 1 696.14 | - 189.71 | 1 229.46 |
| Income taxes | - 153.54 | - 126.59 | - 402.26 | - 150.22 | |
| Net earnings | 523.67 | 578.40 | 1 293.88 | - 189.71 | 1 079.24 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Buildings | 77.16 | 133.96 | 293.18 | ||
| Machinery and equipment | 239.25 | 86.94 | 107.67 | 407.41 | |
| Tangible assets total | 239.25 | 164.10 | 241.63 | 700.59 | |
| Investments total | 2.33 | ||||
| Non-curr. owed by group member comp. | 775.10 | ||||
| Long term receivables total | 775.10 | ||||
| Inventories total | |||||
| Current trade debtors | 833.73 | 2 590.36 | 3 530.47 | 6 338.95 | 7 546.06 |
| Current amounts owed by group member comp. | 400.10 | 1 020.10 | |||
| Short term receivables total | 1 233.83 | 2 590.36 | 4 550.57 | 6 338.95 | 7 546.06 |
| Cash and bank deposits | 113.89 | 24.60 | |||
| Cash and cash equivalents | 113.89 | 24.60 | |||
| Balance sheet total (assets) | 1 347.72 | 3 629.31 | 4 714.67 | 6 580.58 | 8 248.98 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Shares repurchased | 500.00 | 1 000.00 | 1 000.00 | ||
| Retained earnings | 23.67 | - 883.14 | 410.73 | - 778.98 | |
| Profit of the financial year | 523.67 | 578.40 | 1 293.88 | - 189.71 | 1 079.24 |
| Shareholders equity total | 563.67 | 1 142.06 | 1 450.73 | 261.03 | 1 340.26 |
| Provisions | 6.85 | ||||
| Non-current liabilities total | |||||
| Current loans from credit institutions | 40.38 | 968.82 | 511.66 | ||
| Current trade creditors | 1 029.10 | 388.19 | 2 995.11 | 3 662.93 | |
| Current owed to participating | 9.82 | 395.65 | 42.00 | 1.44 | |
| Current owed to group member | 221.37 | 51.37 | |||
| Short-term deferred tax liabilities | 153.54 | 126.59 | 528.86 | 154.74 | |
| Other non-interest bearing current liabilities | 620.69 | 935.90 | 2 264.51 | 2 132.82 | 2 521.16 |
| Current liabilities total | 784.05 | 2 487.24 | 3 263.94 | 6 319.56 | 6 901.87 |
| Balance sheet total (liabilities) | 1 347.72 | 3 629.31 | 4 714.67 | 6 580.58 | 8 248.98 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated